Prophylactic Application of an Anti-Cytomegalovirus Hyperimmunoglobulin in Allogeneic Bone Marrow Transplant Recipients
1987
Interstitial pneumonia (IP) is still a life-threatening complication after allogeneic bone marrow transplantation (BMT). It is reported to occur in about 40% of all patients [1]. Almost half the cases of IP are associated with cytomegalovirus (CMV), whereas one-third of IP remains idiopathic. CMV-associated IP has a mortality of up to 90% [1].
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
9
References
1
Citations
NaN
KQI